In its section Tendencias (trends), the newspaper La Vanguardia devotes an article to the dilemma that researchers sometimes face, namely to patent or set up a company. Spin-offs are one of the options scientists have in order to take advantage of an important finding and the article cites a few success stories. The author highlights Omnia Molecular, founded by Lluís Ribas de Pouplana, Group Leader of the Gene Translation Laboratory at IRB Barcelona, and Cellzome, created by Cayetano Gonzalez, Group Leader of the Cell Division Laboratory at IRB Barcelona, and Luís Serrano, from CRG.

• Read the news (PDF in Spanish)
• La Vanguardia Online